Guidelines Focused Update Atrial Fib FT
Title Rivaroxaban Versus Warfarin in Nonvalvular Atrial Fibrillation Clinical Trial Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with.
Kenneth W. Mahaffey, MD and Keith AA Fox, MB ChB on behalf of the ROCKET AF Investigators Rivaroxaban Once-daily oral direct factor Xa inhibition Compared.
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with AF: a meta-analysis of randomised trials
Rivaroxaban
